Records containing: Tuberculosis
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2018-06-01Phase III Clinical Study of Efficacy and Safety of Mycobacterium Vaccae to Prevent Tuberculosis in High Risk Groups of Tuberculosis Infection
-
CLINICAL_TRIALS study record update · 2018-05-25Dietary Assessment and Prevalence of Refeeding Syndrome in High-risk TB Patients in Chhattisgarh, India
-
CLINICAL_TRIALS study record update · 2018-05-03Strategic Screening for Infectious Diseases (Tuberculosis, HIV, HBV, HCV) Amongst Migrants in France
-
CLINICAL_TRIALS study record update · 2018-05-01A Randomized, Double-blind, Dose-escalation Clinical Trial of the Safety, Reactogenicity and Immunogenicity of MTBVAC Compared to BCG Vaccine SSI, in Newborns Living in a Tuberculosis Endemic Region With a Safety Arm in Adults
-
CLINICAL_TRIALS study record update · 2018-04-18Phase II Double-blind, Randomized, Controlled Study to Evaluate Safety and Immunogenicity of VPM1002 Compared With BCG in HIV-exposed and HIV-unexposed, BCG-naive Newborn Infants
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2018-04-12For Tuberculosis (TB) Clinical Auxiliary Diagnosis of Recombinant Mycobacterium Tuberculosis Allergen ESAT6 - CFP10 Dose of Certain Phase III Clinical Research
-
CLINICAL_TRIALS study record update · 2018-04-09Phase 1/II, Safety and Immunogenicity Study of a Recombinant Protein Tuberculosis Vaccine (AERAS-404) in BCG-Primed Infants
-
CLINICAL_TRIALS study record update · 2018-04-05A Natural History Study of Tuberculosis in China; Correlates of a Successful Response to Treatment
-
CLINICAL_TRIALS study record update · 2018-04-05Transcriptional Signature of HIV And TB Co-Infection
-
CLINICAL_TRIALS study record update · 2018-04-05A Natural History Study of Multidrug-Resistant Tuberculosis Strains and Host Susceptibility Genes in Korean Patients With Pulmonary Tuberculosis
-
CLINICAL_TRIALS study record update · 2018-04-05Sensitivity and Specificity of Oral Urea Breath Testing for Presumptive Diagnosis and Treatment Response in Pulmonary Tuberculosis in Bamako, Mali
-
CLINICAL_TRIALS study record update · 2018-04-05Establishment of Normal Parameters for Blood and Sputum With Samples Obtained From Volunteers in Bamako
-
CLINICAL_TRIALS study record update · 2018-04-04Test and Treat TB: A Proof of Concept Trial in South Africa
-
CLINICAL_TRIALS study record update · 2018-03-22A Cluster Randomised Trial to Assess the Impact of an Enhanced Case Finding Strategy on Tuberculosis Notification in The Gambia
-
CLINICAL_TRIALS study record update · 2018-03-08CKD Prevalence and the Role of Cardiovascular Risk Factors and Infectious Diseases in a Region of Sub-Saharan Africa
-
CLINICAL_TRIALS study record update · 2018-03-07Maputo Tuberculosis Trial Unit- Project (MaTuTU- Project)
-
CLINICAL_TRIALS study record update · 2018-03-07A Blinded, Cross-sectional, Diagnostic Evaluation Study Performed in Pulmonary TB Suspects at the TB Dispensary for Sector 4 of the Marius-Nasta-Institute in Bucharest, Romania
-
CLINICAL_TRIALS study record update · 2018-02-13A Randomized, Phase 2b Study of a Double-Dose Lopinavir/Ritonavir-Based Antiretroviral Regimen With Rifampin-Based Tuberculosis Treatment Versus a Standard-Dose Lopinavir/Ritonavir-Based Antiretroviral Regimen With Rifabutin-Based Tuberculosis Treatment With or Without Raltegravir in HIV-1-Infected Persons Requiring Treatment for Active TB and HIV
-
CLINICAL_TRIALS study record update · 2018-02-08A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Sutezolid in Healthy Adult Subjects
-
CLINICAL_TRIALS study record update · 2018-02-06Evaluation of Xpert MTB/RIF Assay for the Rapid Identification of TB and TB Rifampin Resistance in HIV-Infected and HIV-Uninfected Pulmonary Tuberculosis Suspects
-
CLINICAL_TRIALS study record update · 2018-02-01ClinicalTrials.gov study NCT02681445
-
CLINICAL_TRIALS study record update · 2018-01-19Preventing Tuberculosis-associated Immune Reconstitution Inflammatory Syndrome in High-risk Patients: a Randomized Placebo-controlled Trial of Prednisone
-
CLINICAL_TRIALS study record update · 2018-01-12Finding and Treating Unsuspected and Resistant TB to Reduce Hospital Transmission
-
CLINICAL_TRIALS study record update · 2017-12-27Evaluation of the Safety and Immunogenicity of the Recombinant Subunit Vaccine "GamTBvac" Against the Tuberculosis. Comparative Placebo-controlled Study With a Two-fold Increase of the Vaccine Dose in Healthy Volunteers Aged 18-49 Years.
-
CLINICAL_TRIALS study record update · 2017-12-26Investigating the Additive Benefit of the Urine Lipoarabinomannan Test to Current TB Diagnostics Among HIV+ Adults in Panama City, Panama